SCHEMBL5620595

SCHEMBL5620595

CCN1[C]=NCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7287866 0.75 GNAO1 (0.34)
SCHEMBL150994 0.63
SCHEMBL9059716 0.61
SCHEMBL9059234 0.54
SCHEMBL9059876 0.53
SCHEMBL42921 0.52
SCHEMBL262312 0.48
SCHEMBL577415 0.48 CHRNA7 (0.48)
SCHEMBL577052 0.48 CHRNA7 (0.48)
SCHEMBL6657817 0.48 CHRNA7 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7244738-B2 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists ROCHE PALO ALTO LLC (US) 2007-07-17 US claimed
US-20050038016-A1 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists ROCHE PALO ALTO LLC 2005-02-17 US claimed
US-RE33907-E Anti-spasmodic agents having a heterocyclic ring UNITED PHARMACEUTICALS, INC. (US) 1992-04-28 US claimed
US-4857535-A THIOESTERS UNITED PHARMACEUTICALS (US) 1989-08-15 US claimed
EP-0278158-A2 Renin inhibitors containing phenylalanyl-histidine replacements MERCK & CO. INC. (US) 1988-08-17 EP claimed
US-4721783-A SMOOTH MUSCLES UNITED PHARMACEUTICALS, INC. (US) 1988-01-26 US claimed
EP-0089041-B1 USE OF A NEGATIVE ACTING PHOTOPOLYMERIZABLE ELEMENT AS A SOLDER MASK E.I. DU PONT DE NEMOURS AND COMPANY (US) 1987-11-25 EP claimed
EP-0089041-A1 Use of a negative acting photopolymerizable element as a solder mask E.I. DU PONT DE NEMOURS AND COMPANY (US) 1983-09-21 EP claimed
US-20070265446-A1 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists CONNOLLY TERRENCE J 2007-11-15 US disclosed
US-7244738-B2 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists ROCHE PALO ALTO LLC (US) 2007-07-17 US disclosed
EP-1644369-A2 ARYLAMINE-SUBSTITUTED QUINAZOLINONE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2006-04-12 EP disclosed
US-20050038016-A1 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists ROCHE PALO ALTO LLC 2005-02-17 US disclosed
WO-2005005395-A2 ARYLAMINE-SUBSTITUTED QUINAZOLINONE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2005-01-20 WO disclosed
US-5684029-A HYPOTENSIVE AGENTS KARL THOMAE GMBH (DE) 1997-11-04 US disclosed
US-4857535-A THIOESTERS UNITED PHARMACEUTICALS (US) 1989-08-15 US disclosed
EP-0278158-A2 Renin inhibitors containing phenylalanyl-histidine replacements MERCK & CO. INC. (US) 1988-08-17 EP disclosed
US-4721783-A SMOOTH MUSCLES UNITED PHARMACEUTICALS, INC. (US) 1988-01-26 US disclosed
US-4497889-A Release compound in negative acting photopolymerizable element E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-02-05 US disclosed
US-4476135-A Amino-2,1,3-benzothiadiazole and -benzoxadiazole derivatives, their preparation and pharmaceutical compositions containing them SANDOZ LTD. (CH) 1984-10-09 US disclosed
EP-0089041-A1 Use of a negative acting photopolymerizable element as a solder mask E.I. DU PONT DE NEMOURS AND COMPANY (US) 1983-09-21 EP disclosed